Diversity is good for business
Insights
By Catherine Lewis La Torre, CEO, British Patient Capital
The latest report from the British Business Bank on female founders and venture capital, has some sobering findings. VC firms currently have few female decision makers: women hold just 13% of senior positions in UK investment teams. Furthermore, whilst UK VC deals in all-female founding teams have increased from seven in 2007 to 39 in 2017. This means over the past decade the increase from 2.7% to 4.4% amounts to just 0.2% growth per year.
Last year to mark International Women’s Day I wrote about my own experience of diversity, how it has influenced me and as a team leader. I discussed how I have actively set-up diverse teams as I believe it really does drive good business.
Since October, I have also become the CEO of British Patient Capital, and again have a marvellously diverse team. British Patient Capital are active proponents of increasing the spotlight in this area and are enhancing the diversity aspect of our due diligence by adopting the recently launched Institutional Limited Partner Association (ILPA), diversity template. I’m also proud that a member of the British Patient Capital team, Anu Adebajo, sits on the ILPA Diversity & Inclusion Committee which created ILPA template.
There is growing consensus that diversity is a critical success factor for high performing teams. As a leading Limited Partner (LP) in UK VC, if we aren’t actively promoting the necessity for diverse teams with the General Partners (GPs) we back, then we are failing in our mission to spread best practice and, importantly, missing out on better financial performance. The in-built caution of LPs as institutions means that changes in our focus are gradual but when they occur, they tend to be permanent. For diversity and inclusion, it’s clear such a change in focus has happened – we now need GPs to help us deliver.
Latest news
-
Read more about British Patient Capital announces £8m investment into Tokamak Energy as part of $125m financing round Press release
20 November 2024 -
Read more about British Patient Capital – Full Year Results for the period ending 31 March 2024 Press release
04 November 2024 -
Read more about British Patient Capital announces £8m investment into Nuclera as part of a $75m Series C financing round Press release
16 October 2024